📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.
Get business pricing on tech for your team
- Business-only prices and quantity discounts
- Tax-exempt purchasing
- Multiple users, one account, clear invoices
TL;DR
A new vertigo relief app is in development to assist adults with BPPV in performing repositioning maneuvers at home. It aims to improve self-treatment, reduce relapse, and support clinical workflows, amid growing telehealth adoption.
A new vertigo relief app is currently being tested to assist adults suffering from recurrent positional vertigo and BPPV in performing repositioning maneuvers correctly at home. This development aims to address long wait times for specialist care and improve self-management, with potential integration into ENT and vestibular clinics, according to sources familiar with the project.
The app is designed for adults, skewing female and older, who experience recurrent BPPV episodes. It will feature guided step-by-step instructions for maneuvers like the Epley and Brandt-Daroff, using animated visuals, audio cues, and gyroscope-based head-angle feedback from smartphones. For more on how technology is aiding in vestibular therapy, see this guest app with day-of seating lookup and schedule. Additionally, it will log dizziness episodes, triggers, and severity over time, providing patients and clinicians with valuable data.
Developers plan to validate the app through a combination of targeted online ads, measuring signups and completion rates of maneuver flows, as well as pitching to ENT, audiology, and physiotherapy clinics to gauge interest in recommending the tool for between-visit home care. The app will carry disclaimers emphasizing it is not a substitute for medical advice but aims to support self-treatment and relapse prevention.
Potential Impact on Vestibular Disorder Management
This app could significantly improve self-treatment accuracy for BPPV, reducing relapse rates which occur in roughly half of cases. It also offers a scalable, low-cost solution that complements existing clinical care, especially as telehealth and digital therapeutics adoption grow. For clinics, white-labeling the app could streamline patient follow-up and home-based rehab, potentially easing healthcare system burdens and improving patient outcomes.
Products Worth Considering
DJI Osmo Mobile 8 Gimbal with Mic Mini Transmitter, Infinity Black
DJI Osmo Mobile 7P Phone Gimbal with Mic Mini Transmitter, Infinity Black
Logitech MX Mechanical Wireless Illuminated Keyboard, Tactile Quiet, Graphite
As an affiliate, we earn on qualifying purchases.
Rise of Digital Solutions in Vestibular Care
The digital therapeutics market for vestibular disorders was valued at approximately USD 498 million in 2024, with a projected CAGR of 13.5% through 2033. COVID-19 accelerated the shift toward remote care, making smartphone-based solutions more viable due to advances in motion sensors and telehealth reimbursement policies. Existing self-management tools often lack real-time guidance, which this app aims to provide, addressing a critical gap in patient care.
“This app could transform how patients manage BPPV at home, combining real-time feedback with symptom tracking to improve outcomes.”
— an anonymous researcher
Unclear Aspects of App Validation and Adoption
It is not yet clear how effective the app will be in real-world settings, as validation studies and clinical trials are still in planning or early testing phases. Additionally, the extent of clinician willingness to recommend or white-label the app remains to be seen, along with regulatory considerations and reimbursement pathways for digital therapeutics targeting vestibular disorders.
Next Steps in App Testing and Market Integration
Developers plan to launch a lightweight landing page, run targeted ads to measure user engagement, and conduct pilot studies with ENT and physiotherapy clinics. Successful validation could lead to wider clinical trials, formal regulatory approval, and integration into standard vestibular care pathways. Further, partnerships with healthcare providers and payers are expected to shape the app’s commercial rollout in 2025.
Key Questions
How does the vertigo relief app guide users through maneuvers?
The app provides animated step-by-step visual instructions, audio cues, and uses smartphone gyroscope sensors to give real-time head-angle feedback, ensuring proper execution of maneuvers like the Epley.
Can this app replace seeing a healthcare professional?
No, the app is designed to support self-management but explicitly states it is not a substitute for professional medical advice. Users should consult a clinician if red-flag symptoms occur.
Will clinics be able to white-label or license the app?
Yes, one of the development goals is to offer a version that clinics can license for patient home programs, potentially integrating it into existing vestibular care workflows.
When will the app be available for general use?
The app is currently in testing and validation phases. A wider release is expected after successful clinical validation and regulatory review, likely in late 2025 or early 2026.
What are the main features of the app?
The core features include guided repositioning maneuvers, symptom and episode logging, and optional advanced tracking and reminders for ongoing management.
Source: IdeaNavigator AI
